Visos teiss saugomos
(1997) 273:E9818
This customized formulation is prepared by state-licensed compounding pharmacies and is not FDA-approved
This indicates that the model adequately fits the data, and the observed variations can be attributed to random error
H., Yuan, L
DNA Constructs As shown in Figure S4B in Supplementary Material, pcDNA3.1-Flag-GSTP, pcDNA3.1-Flag-HMGB1, pcDNA3.1-Flag-GSTM, six GSTP phosphorylation mutants including pcDNA3.1-Flag-GSTP-S42A (in which serine-42 was mutated to alanine, a S42 non-phosphorylatable mutant), pcDNA3.1-Flag-GSTP-S42D (in which serine-42 was mutated to aspartate, a Ser42 constant-phosphomimetic mutant), pcDNA3.1-Flag-GSTP-S184A (in which serine-184 was mutated to alanine, a Ser184 non-phosphorylatable mutant), pcDNA3.1-Flag-GSTP-S184D (in which serine-184 was mutated to aspartate, a Ser184 constant-phosphomimetic mutant), pcDNA3.1-Flag-GSTP-Y198F (in which tyrosine-198 was mutated to phenylalanine, a Tyr198 non-phosphorylatable mutant) and pcDNA3.1-Flag-GSTP-Y198D (in which tyrosine-198 was mutated to aspartate, a Tyr198 constant-phosphomimetic mutant), pET28a-HMGB1, pET28a-GSTP(WT), pET28a-GSTP(S184A), pET28a-GSTP(S184D) were constructed by using molecular cloning technology
